Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-bind, Randomised, Placebo Controlled Study of Ulinastatin in Severe Acute Pancreatitis

NCT01132521 is registered in ClinicalTrials.gov with Techpool Bio-Pharma Co., Ltd. as lead sponsor.

NCT NCT01132521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01132521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-bind, Randomised, Placebo Controlled Study of Ulinastatin in Severe Acute Pancreatitis
Lead sponsor
Techpool Bio-Pharma Co., Ltd.
Phase
Phase 4
Overall status
Suspended
Start date
June 30, 2010
Completion date
December 31, 2018
Enrollment
252 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis